Records containing: Overactive Bladder

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

• CLINICAL_TRIALS study record update · 2012-10-23
  Randomized Controlled Trial of Tolterodine in Combination With or Without Low-Dose Intravaginal Estradiol Cream for the Treatment of Overactive Bladder in Post-Menopausal Women
• CLINICAL_TRIALS study record update · 2012-10-12
  Controlled Study of ONO-8025 (KRP-197) in Patients With Overactive Bladder in Japan
• CLINICAL_TRIALS study record update · 2012-10-11
  Controlled Study of ONO-8025 (KRP-197) in Patients With Overactive Bladder in Japan
• CLINICAL_TRIALS study record update · 2012-08-16
  ClinicalTrials.gov study NCT01178827
• CLINICAL_TRIALS study record update · 2012-08-14
  A Randomized, Double Blind, Placebo Controlled, Parallel Group, Multicenter Trial To Evaluate The Efficacy And Safety Of A Fesoterodine Flexible Dose Regimen In Patients With Symptoms Of Overactive Bladder Including Nocturnal Urinary Urgency.
• Organize your saved records without ads with Plus.
• CLINICAL_TRIALS study record update · 2012-07-19
  Urgent-SQ Implant in Treatment of Overactive Bladder Syndrome: Nine-year Follow-up Study
• CLINICAL_TRIALS study record update · 2012-06-14
  A Randomised, Multi-Centre, Double-Blind, Placebo and Active-Controlled, 5-Way Parallel Group Study to Investigate the Efficacy, Safety and Tolerability of ONO-8539 in Patients With Overactive Bladder
• CLINICAL_TRIALS study record update · 2012-06-14
  Postmarketing Observational Study of Tolterodine Treatment on Overactive Bladder in Real Life Setting
• CLINICAL_TRIALS study record update · 2012-06-13
  An Open-label Study to Evaluate the Long-term Safety and Efficacy of Imidafenacin in Patients With Overactive Bladder
• CLINICAL_TRIALS study record update · 2012-05-30
  Feasibility of "At-home" Titration of Solifenacin 5 and 10mg and Effect on Symptoms and Quality of Life in a Typical OAB Population
• CLINICAL_TRIALS study record update · 2012-04-16
  Phase IV Study to Evaluate the Efficacy and Safety Imidafenacin Versus Fesoterodine in Patients With Overactive Bladder
• CLINICAL_TRIALS study record update · 2012-04-02
  A Double-blind, Randomized, Sham-controlled, Multicenter Clinical Trial to Assess the Effectiveness of Therapeutic Class IV Laser LCT-1000TM Treatment for Overactive Bladder Syndrome.
• CLINICAL_TRIALS study record update · 2012-03-15
  A 13-Week, Single-Arm, Open-Label, Multicenter Study To Evaluate Refill Adherence And Satisfaction With Fesoterodine Plus "Your Way" Patient Support Plan In Patients With Symptoms Of Overactive Bladder.
• CLINICAL_TRIALS study record update · 2012-02-02
  A Randomized, Double-blind, Placebo and Active-controlled Efficacy and Safety Study of SSR240600C in Patients With Overactive Bladder (OAB) or Urge Urinary Incontinence (UUI)
• CLINICAL_TRIALS study record update · 2012-01-25
  Phase III Study of Propiverine Hydrochloride Extended-Release Capsule in the Treatment of Overactive Bladder (OAB) in Chinese Population With Urgent Micturition, Frequent Micturition and/or Urge Urinary Incontinence
• CLINICAL_TRIALS study record update · 2012-01-19
  Treatment of the Overactive Bladder in Postmenopausal Women With Bryophyllum Pinnatum Versus Placebo (a Multicenter, Prospective, Double-blind Randomised, Placebo-controlled Clinical Pilot Study, Phase II Drug Study)
• CLINICAL_TRIALS study record update · 2011-12-19
  ClinicalTrials.gov study NCT00863551
• CLINICAL_TRIALS study record update · 2011-11-30
  Multicenter Assessment of Transdermal Therapy in Overactive Bladder With Oxybutynin TDS (MATRIX)
• CLINICAL_TRIALS study record update · 2011-11-24
  A Multi-center, Randomized, Placebo-controlled Clinical Trial Comparing Fesoterodine to Placebo in Women Diagnosed With Urge Urinary Incontinence by the 3 Incontinence Questions (3IQ). Followed by a Multi-center Open Label Clinical Cohort Study of Long-term Effects of Treatment With Fesoterodine.
• CLINICAL_TRIALS study record update · 2011-11-17
  An Open-Label, Dose-Escalating Study Of The Pharmacokinetics, Safety And Tolerability Of Fesoterodine In Pediatric Overactive Bladder Patients Aged 8-17 Years.
• CLINICAL_TRIALS study record update · 2011-11-17
  ClinicalTrials.gov study NCT00189800
• CLINICAL_TRIALS study record update · 2011-10-28
  Hypnotherapy for Treatment of Overactive Bladder: A Feasibility Study
• CLINICAL_TRIALS study record update · 2011-10-17
  ClinicalTrials.gov study NCT00311376
• CLINICAL_TRIALS study record update · 2011-10-17
  ClinicalTrials.gov study NCT00575016
• CLINICAL_TRIALS study record update · 2011-10-17
  ClinicalTrials.gov study NCT00461292